Bristol Myers Squibb CoUSD 2.00 Cum.Conv News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

26.07.24	Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday (Benzinga)
22.07.24	A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts (Benzinga)
18.07.24	What the Options Market Tells Us About Bristol-Myers Squibb (Benzinga)
15.07.24	Bristol-Myers Squibb Unusual Options Activity For July 15 (Benzinga)
10.07.24	Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity (Benzinga)
28.06.24	Is Bristol Myers Squibb Stock a Buy? (MotleyFool)
26.06.24	What the Options Market Tells Us About Bristol-Myers Squibb (Benzinga)
18.06.24	This Is What Whales Are Betting On Bristol-Myers Squibb (Benzinga)
18.06.24	Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb (MotleyFool)
04.06.24	Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients (Benzinga)
03.06.24	Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday (Benzinga)
21.05.24	Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity (Benzinga)
03.05.24	Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire? (MotleyFool)
03.05.24	If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today (MotleyFool)
26.04.24	Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights (Benzinga)
25.04.24	Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions (Benzinga)
25.04.24	Why Bristol Myers Squibb Stock Is Sinking Today (MotleyFool)
25.04.24	Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript (MotleyFool)
25.04.24	Is Bristol Myers Squibb Stock a Millionaire Maker? (MotleyFool)
25.04.24	Bristol Myers Squibb shares fall amid sluggish sales of some newer drugs (MarketWatch)
25.04.24	Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma (Financial Times)
23.04.24	Pharmabranche: Neuer Novartis-Chef kommt von Bristol Myers Squibb (Handelsblatt)
23.04.24	Ex-Chef von Bristol Myers Squibb soll Novartis kontrollieren (manager magazin online)
15.04.24	Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? (MotleyFool)
11.04.24	This Is What Whales Are Betting On Bristol-Myers Squibb (Benzinga)
28.03.24	Is Bristol Myers Squibb Stock a Buy? (MotleyFool)
15.03.24	Bristol Myers Squibb cell therapy gets FDA green light to treat common type of leukemia (MarketWatch)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V